Irene A Burger
A third of the radiotracer dose: two decades of progress in pediatric [F]fluorodeoxyglucose PET/CT and PET/MR imaging.
Wälti S, Skawran S, Sartoretti T, Schwyzer M, Gennari A, Mader C, Treyer V, Kellenberger C, Burger I, Hany T, Maurer A, Huellner M, Messerli M. A third of the radiotracer dose: two decades of progress in pediatric [F]fluorodeoxyglucose PET/CT and PET/MR imaging. Eur Radiol 2023
Oct 19, 2023A third of the radiotracer dose: two decades of progress in pediatric [F]fluorodeoxyglucose PET/CT and PET/MR imaging.
Oct 19, 2023Eur Radiol 2023
Wälti Stephan, Skawran Stephan, Sartoretti Thomas, Schwyzer Moritz, Gennari Antonio G, Mader Caecilia, Treyer Valerie, Kellenberger Christian J, Burger Irene A, Hany Thomas F, Maurer Alexander, Huellner Martin W, Messerli Michael
Fully automated computational measurement of noise in positron emission tomography.
Sartoretti T, Skawran S, Gennari A, Maurer A, Euler A, Treyer V, Sartoretti E, Wälti S, Schwyzer M, von Schulthess G, Burger I, Huellner M, Messerli M. Fully automated computational measurement of noise in positron emission tomography. Eur Radiol 2023
Aug 30, 2023Fully automated computational measurement of noise in positron emission tomography.
Aug 30, 2023Eur Radiol 2023
Sartoretti Thomas, Skawran Stephan, Gennari Antonio G, Maurer Alexander, Euler André, Treyer Valerie, Sartoretti Elisabeth, Wälti Stephan, Schwyzer Moritz, von Schulthess Gustav K, Burger Irene A, Huellner Martin W, Messerli Michael
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.
Templeton A, Omlin A, Berthold D, Beyer J, Burger I, Eberli D, Engeler D, Fankhauser C, Fischer S, Gillessen S, Nicolas G, Kroeze S, Lorch A, Müntener M, Papachristofilou A, Schäfer N, Seiler D, Stenner-Liewen F, Tsantoulis P, Vlajnic T, Zilli T, Zwahlen D, Cathomas R. Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer. Swiss Med Wkly 2023; 153:40108.
Aug 15, 2023Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.
Aug 15, 2023Swiss Med Wkly 2023; 153:40108
Templeton Arnoud J, Omlin Aurelius, Berthold Dominik R, Beyer Jörg, Burger Irene A, Eberli Daniel, Engeler Daniel, Fankhauser Christian Daniel, Fischer Stefanie, Gillessen Silke, Nicolas Guillaume, Kroeze Stephanie G C, Lorch Anja, Müntener Michael, Papachristofilou Alexandros, Schäfer Niklaus G, Seiler Daniel, Stenner-Liewen Frank, Tsantoulis Petros, Vlajnic Tatjana, Zilli Thomas, Zwahlen Daniel Rudolf, Cathomas Richard
Focal unspecific bone uptake on [F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging
Grünig H, Maurer A, Thali Y, Kovacs Z, Strobel K, Burger I, Müller J. Focal unspecific bone uptake on [F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging. Eur J Nucl Med Mol Imaging 2021; 48:4483-4494.
Jun 13, 2021Focal unspecific bone uptake on [F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging
Jun 13, 2021Eur J Nucl Med Mol Imaging 2021; 48:4483-4494
Grünig Hannes, Maurer Alexander, Thali Yannick, Kovacs Zsofia, Strobel Klaus, Burger Irene A, Müller Joachim
Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer
Gnesin S, Prior J, Treyer V, Kaufmann P, Ametamey S, Schibli R, Müller C, Choschzick M, Früh M, Siano M, Meisel A, Burger I, Müller J, Schaefer N. Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer. EJNMMI Res 2020; 10:32.
Apr 8, 2020Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer
Apr 8, 2020EJNMMI Res 2020; 10:32
Gnesin Silvano, Prior John O, Treyer Valerie, Kaufmann Philipp A, Ametamey Simon M, Schibli Roger, Müller Cristina, Choschzick Matthias, Früh Martin, Siano Marco, Meisel Alexander, Burger Irene A, Müller Joachim, Schaefer Niklaus
Impact of Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
Ferraro D, Hermanns T, Kaufmann P, Omlin A, Kranzbühler H, Gablinger R, Müller A, Müller J, Eberli D, Muehlematter U, Garcia Schüler H, Burger I. Impact of Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer. Eur J Nucl Med Mol Imaging 2019
Dec 4, 2019Impact of Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
Dec 4, 2019Eur J Nucl Med Mol Imaging 2019
Ferraro Daniela A, Hermanns Thomas, Kaufmann Philipp A, Omlin Aurelius, Kranzbühler Helmut, Gablinger Roger, Müller Alexander, Müller Julian, Eberli Daniel, Muehlematter Urs J, Garcia Schüler Helena I, Burger Irene A
First clinico-pathological evidence of a non PSMA-related uptake mechanism for Ga-PSMA-11 in salivary glands
Rupp N, Schibli R, Eberli D, Huber G, Morand G, Messerli M, Ferraro D, Mühlematter U, Müller J, Töpfer A, Lenggenhager D, Pizzuto D, Umbricht C, Burger I. First clinico-pathological evidence of a non PSMA-related uptake mechanism for Ga-PSMA-11 in salivary glands. J Nucl Med 2019
Feb 8, 2019First clinico-pathological evidence of a non PSMA-related uptake mechanism for Ga-PSMA-11 in salivary glands
Feb 8, 2019J Nucl Med 2019
Rupp Niels J, Schibli Roger, Eberli Daniel, Huber Gerhard, Morand Grégoire B, Messerli Michael, Ferraro Daniela A, Mühlematter Urs Jacob, Müller Julian, Töpfer Antonia, Lenggenhager Daniela, Pizzuto Daniele A, Umbricht Christoph A, Burger Irene A
Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
Müller J, von Schulthess G, Kaufmann P, Kranzbuehler H, John H, Zilli T, Müller A, Omlin A, Schmid D, Sulser T, Kroeze S, Guckenberger M, Eberli D, Kedzia S, Garcia Schüler H, Muehlematter U, Ferraro D, Burger I. Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction. Eur J Nucl Med Mol Imaging 2018
Nov 28, 2018Clinical impact of Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction
Nov 28, 2018Eur J Nucl Med Mol Imaging 2018
Müller Julian, von Schulthess Gustav K, Kaufmann Philipp A, Kranzbuehler Helmut, John Hubert, Zilli Thomas, Müller Alexander, Omlin Aurelius, Schmid Daniel M, Sulser Tullio, Kroeze Stephanie G C, Guckenberger Matthias, Eberli Daniel, Kedzia Sarah, Garcia Schüler Helena I, Muehlematter Urs J, Ferraro Daniela A, Burger Irene A
Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT
Sekine T, Veit-Haibach P, von Schulthess G, Kollias S, Huber G, Ter Voert E, Stolzmann P, Burger I, Delso G, Barbosa F, Huellner M. Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT. Head & neck 2017; 39:1550-1558.
May 13, 2017Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT
May 13, 2017Head & neck 2017; 39:1550-1558
Sekine Tetsuro, Veit-Haibach Patrick, von Schulthess Gustav K, Kollias Spyros S, Huber Gerhard, Ter Voert Edwin E, Stolzmann Paul, Burger Irene A, Delso Gaspar, Barbosa Felipe de Galiza, Huellner Martin W
PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system
Sekine T, Veit-Haibach P, von Schulthess G, Kollias S, Huber G, Stolzmann P, Burger I, Kuhn F, de Galiza Barbosa F, Huellner M. PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system. Clin Imaging 2017; 42:232-239.
Jan 17, 2017PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system
Jan 17, 2017Clin Imaging 2017; 42:232-239
Sekine Tetsuro, Veit-Haibach Patrick, von Schulthess Gustav K, Kollias Spyros S, Huber Gerhard, Stolzmann Paul, Burger Irene A, Kuhn Felix P, de Galiza Barbosa Felipe, Huellner Martin W
The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction
Müller J, Hüllner M, Strobel K, Huber G, Burger I, Haerle S. The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction. Laryngoscope 2015; 125:1861-8.
Apr 17, 2015The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction
Apr 17, 2015Laryngoscope 2015; 125:1861-8
Müller Julian, Hüllner Martin, Strobel Klaus, Huber Gerhard, Burger Irene A, Haerle Stephan K